CClinicalTrials.gg
Status unknownNCT04793022TIVAUpdated Feb 8, 2023

Total Intravenous Anesthesia With Propofol vs. General Anesthesia in Outpatient Shoulder Arthroscopic Surgeries

A Phase 4 interventional study of TIVA with Propofol and Inhaled Anesthesia in Rotator Cuff Tears, Rotator Cuff Injuries and Orthopedic Disorder, sponsored by Carilion Clinic. Status unknown at 1 site in United States. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-02-08.

Sponsored by Carilion Clinic · Phase 4, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jan 2023), so the status shown — last known as Enrolling by invitation — may be out of date.
Phase
Phase 4
Study type
Interventional
Enrollment
192
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This study is comparing total intravenous anesthesia with propofol with a regional nerve block against general anesthesia with a regional nerve block on the primary endpoint of time to meet discharge criteria.

Read the detailed description

The primary objective of this study is to determine if using Total Intravenous Anesthesia with Propofol (TIVA-P sedation) with a regional nerve block will decrease the time to meet discharge criteria. This will be done with patients undergoing shoulder arthroscopic procedures at the Roanoke Ambulatory Surgical Center. Currently, inhaled general anesthesia (GA) with a regional nerve block is utilized for these outpatient arthroscopic procedures. This involves the patient receiving Propofol through an IV to put a patient to sleep, followed by intubation (breathing tube in throat) and the administration of inhaled anesthesia for the duration of the procedure. Another approach for anesthesia in these procedures is TIVA-P sedation. In this protocol the patient receives the same initial amount of Propofol through the IV as they would if they were getting general anesthesia. Once they are asleep, it is maintained with a continuous intravenous administration of Propofol. With this approach, the patient is not intubated and exposed to the same anesthetic agents as general anesthesia. As a result, the patient may not experience the potential side effects associated with general anesthesia. We believe that this will lead to a faster time to meet discharge criteria and also fewer of anesthetic side effects.

02

Conditions studied

  • Rotator Cuff Tears
  • Rotator Cuff Injuries
  • Orthopedic Disorder
  • Sports Injury
  • Anesthesia
03

In context

Musculoskeletal Diseases

657 studies on the registry are indexed under Musculoskeletal Diseases; 159 are open to participants now.

This study's planned enrollment of 192 is above the median of 73 across 438 interventional studies indexed under Musculoskeletal Diseases.

Browse Musculoskeletal Diseases studies →

Lead sponsor

Carilion Clinic is the lead sponsor of 71 studies on the registry; 13 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 2 (22%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 18-75 years of age
  • Candidate for a shoulder arthroscopic procedure in the beach chair position

Exclusion criteria

Exclusion Criteria:

  • American Society of Anesthesiologists (ASA) level 4 or above
  • History of brachial plexus injury
  • Chronic Obstructive Pulmonary Disorder
  • Unstable Asthma
  • BMI greater than 40
  • Allergy to local anesthesic (bupivacaine)
  • Contralateral phrenic nerve impairment
  • History of Difficult Airway
  • Poorly Controlled Gastroesophageal Reflux Disease
  • Known Aspiration Risk
  • Surgery not performed at the Roanoke Ambulatory Surgical Center
  • Pregnant patients or patients who have a positive pre-operative human chorionic gonadotropin (beta-HCG) pregnancy test
  • Coagulopathies
  • Allergy to propofol
  • Patient request for specific anesthesia method
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
192 participants (estimated)

Study arms

  • Experimental
    TIVA-Propofol

    Intravenous anesthesia with Propofol

    Drug: TIVA with Propofol

  • Active comparator
    Inhaled Anesthesia

    General Inhaled Anesthesia

    Drug: Inhaled Anesthesia

Interventions

  • DrugTIVA with Propofol

    Total intravenous anesthesia with propofol

    Also known as: Propofol

  • DrugInhaled Anesthesia

    General anesthesia given with inhaled anesthetics

    Also known as: General Anesthesia

06

What researchers measure

Primary outcomes

  1. Time to meet discharge criteria

    How long it takes until the patient is ready to be discharged from the PACU

    Time frame: Immediately after the intervention/procedure/surgery

Secondary outcomes

  1. Pain Scale

    Pain measured via pain scale: 0 through 5. 0 is no pain, 5 is worst pain ever felt.

    Time frame: Baseline, pre-intervention/procedure/surgery, and up to 21 days after procedure.

  2. Number of procedures requiring anesthetic intervention during surgery

    Use of preoperative interventions including vasopressors, antiemetics, sedatives

    Time frame: During the intervention/procedure/surgery

  3. Satisfaction scale

    How satisfied the patient is with their treatment, scale is rated "1-Poor, 2-Average, 3-Good, 4-Excellent" with higher numbers equating to more patient satisfaction.

    Time frame: Up to 21 days after procedure.

  4. post-anaesthesia care unit (PACU) I to post-anaesthesia care unit (PACU) II transition time

    The amount of time it takes to go from PACU I to PACU II

    Time frame: Immediately after the intervention/procedure/surgery

  5. Antiemetic use in PACU

    Counting dosage of antiemetic use in PACU.

    Time frame: Immediately after the intervention/procedure/surgery

  6. Surgical time

    Time patient is in surgery.

    Time frame: During the intervention/procedure/surgery

07

Study locations

1 site
  • Carilion Clinic Institute of Orthopedics and Neurosurgery
    Roanoke, Virginia 240176, United States
08

References and documents

Individual participant data

Plan to share: No — Data will be collected, de-identified, and published in a manuscript once the study is completed.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 8, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04793022
Lead sponsor
Carilion Clinic
Responsible party
Sponsor
First posted
Mar 11, 2021
Start date
Feb 2, 2021
Primary completion
Aug 1, 2023 (estimated)
Completion
Aug 1, 2023 (estimated)
Last update
Feb 8, 2023

Study contacts

John Tuttle, MD, MS
principal investigator · Carilion Clinic Ortho Surgeon

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion